NCT05733728 Retrospective Register for Uveal Melanoma
| NCT ID | NCT05733728 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Medical University of Vienna |
| Condition | Uveal Melanoma |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,400 participants |
| Start Date | 2023-01-23 |
| Primary Completion | 2030-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,400 participants in total. It began in 2023-01-23 with a primary completion date of 2030-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Background: Uveal melanoma (UM) is a common primary ocular malignancy associated with limited overall survival in the advanced stage of the disease. Fundamental breakthrough regarding the management of the disease and the overall-survival have not yet been achieved. Studies with large cohorts are difficult to perform due to limited patient numbers, therefore retrospective analyses are of great potential to gain further knowledge in a disease with high clinical needs. Aim: The proposed project is a register for patients with UM treated at the Department of Ophthalmology and Optometry at the Medical University of Vienna between 01.01.1997 and 31.12.2021. Patients and Methods: Patients treated for UM at the Department of Ophthalmology and Optometry at the Medical University of Vienna between 01.01.1997 and 31.12.2021 will be included in the register. Information on the baseline characteristics, survival times and course of the disease will be gathered via retrospective chart review and saved in a password-secured database.
Eligibility Criteria
Inclusion Criteria * Patients 18 - 99 years * Diagnosis of uveal melanoma Exclusion Criteria * Patients younger than 18 years of age * Inadequate or missing information on the clinical course in patient charts
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05733728 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 99 Years, studying Uveal Melanoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05733728 currently recruiting?
Yes, NCT05733728 is actively recruiting participants. Contact the research team at reinhard.told@meduniwien.ac.at for enrollment information.
Where is the NCT05733728 trial being conducted?
This trial is being conducted at Vienna, Austria.
Who is sponsoring the NCT05733728 clinical trial?
NCT05733728 is sponsored by Medical University of Vienna. The trial plans to enroll 1,400 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.